MeSH term
Frequency | Condition_Probility | Animals | 3 | 0.0 |
Antigens, Neoplasm/*immunology | 2 | 1.0 |
Comparative Study | 4 | 0.0 |
Humans | 17 | 0.0 |
Male | 11 | 0.0 |
Mice | 2 | 0.0 |
T-Lymphocytes, Cytotoxic/immunology | 4 | 1.0 |
Tumor Cells, Cultured | 9 | 0.0 |
Acute Disease | 3 | 0.0 |
Child | 3 | 0.0 |
Female | 9 | 0.0 |
Gene Expression | 3 | 0.0 |
Neoplasm, Residual | 2 | 2.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Adult | 4 | 0.0 |
Antigens, Neoplasm/*genetics | 5 | 7.0 |
Middle Aged | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 10 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Immunotherapy | 3 | 0.0 |
Testis/metabolism | 2 | 0.0 |
Time Factors | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Base Sequence | 3 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Melanoma/*immunology | 3 | 3.0 |
Antigens, Neoplasm/*metabolism | 2 | 2.0 |
Aged | 3 | 0.0 |
